Allogene Therapeutics, Inc. 10-K filing
Filed 2026-03-12 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001628280-26-017242
- Form type
- 10-K
- CIK
- 0001737287
- Primary document
- https://www.sec.gov/Archives/edgar/data/1737287/000162828026017242/allo-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Allogene Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $0 | - | - |
| Operating Income | $-209.3M | - | - |
| Net Income | $-190.9M | - | - |
| Eps Basic | -0.87 | - | - |
| Eps Diluted | -0.87 | - | - |
| Cash And Equivalents | $51.7M | - | - |
| Total Assets | $415.9M | - | - |
| Total Liabilities | $123.4M | - | - |
| Shareholders Equity | $292.5M | - | - |
| Operating Cash Flow | $-149.2M | - | - |
| Capital Expenditures | $386,000 | - | - |